Ascendis Health Limited (JSE:ASC)
South Africa
· Delayed Price · Currency is ZAR · Price in ZAc 83.00
-3.00 (-3.49%)
May 30, 2025, 5:02 PM SAST
Ascendis Health Cash Flow Statement
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 |
| Net Income | 57.29 | 75.32 | 449.2 | -1,091 | -965.81 |
| Depreciation & Amortization | 57.05 | 76.4 | 79.83 | 85.28 | 143.63 |
| Other Amortization | - | - | 18.98 | 5.93 | 43.63 |
| Loss (Gain) From Sale of Assets | -81.06 | -82.7 | -54.16 | 299.69 | -0.88 |
| Asset Writedown & Restructuring Costs | 28.92 | 128.81 | 169.8 | 85.95 | 462.7 |
| Loss (Gain) From Sale of Investments | 3.13 | 4.13 | 6.86 | 4.39 | 20.16 |
| Provision & Write-off of Bad Debts | 11.49 | 3.23 | 50.34 | 16.03 | 14.39 |
| Other Operating Activities | -20.67 | -333.47 | -852.3 | 304.99 | -234.39 |
| Change in Accounts Receivable | -16.69 | 4.64 | -62.6 | 73.27 | 108.85 |
| Change in Inventory | 33.4 | -94.35 | 17.35 | 27.23 | -38.14 |
| Change in Accounts Payable | -73.39 | 99.22 | -32.61 | -71.46 | 114.91 |
| Change in Other Net Operating Assets | -7.59 | -12.74 | -8.29 | 84.05 | -15.84 |
| Operating Cash Flow | -8.11 | -140.39 | -93.59 | 646.48 | 224.84 |
| Operating Cash Flow Growth | - | - | - | 187.53% | 14.37% |
| Capital Expenditures | -37.09 | -35.73 | -55.55 | -38.57 | -43.28 |
| Sale of Property, Plant & Equipment | 5.97 | 29.68 | 6.9 | 0.37 | 7.15 |
| Divestitures | 21.93 | 432.2 | - | - | - |
| Sale (Purchase) of Intangibles | -8.65 | -0.12 | -0.25 | 23.17 | -2.27 |
| Investment in Securities | -2.48 | 49.69 | - | 2.64 | -16.15 |
| Other Investing Activities | 0 | - | 1,094 | -255.66 | 109.43 |
| Investing Cash Flow | -20.33 | 475.72 | 1,045 | -268.05 | 54.88 |
| Long-Term Debt Issued | - | - | 48.73 | 150.65 | 636.59 |
| Total Debt Issued | - | - | 48.73 | 150.65 | 636.59 |
| Long-Term Debt Repaid | -31.13 | -551.92 | -1,162 | -122.01 | -810.71 |
| Total Debt Repaid | -31.13 | -551.92 | -1,162 | -122.01 | -810.71 |
| Net Debt Issued (Repaid) | -31.13 | -551.92 | -1,114 | 28.64 | -174.12 |
| Issuance of Common Stock | - | 101.53 | - | - | - |
| Repurchase of Common Stock | - | - | -2.12 | - | - |
| Other Financing Activities | 0 | -0.14 | -157.68 | -295.52 | -190.57 |
| Financing Cash Flow | -31.13 | -450.53 | -1,273 | -266.88 | -364.68 |
| Foreign Exchange Rate Adjustments | - | - | -1.95 | 24.11 | 37.31 |
| Miscellaneous Cash Flow Adjustments | - | 4.4 | 171.27 | -113.73 | -5.48 |
| Net Cash Flow | -59.57 | -110.79 | -152.89 | 21.93 | -53.13 |
| Free Cash Flow | -45.2 | -176.11 | -149.14 | 607.91 | 181.56 |
| Free Cash Flow Growth | - | - | - | 234.83% | - |
| Free Cash Flow Margin | -3.07% | -11.47% | -9.56% | 33.30% | 8.24% |
| Free Cash Flow Per Share | -0.07 | -0.29 | -0.31 | 1.26 | 0.38 |
| Cash Interest Paid | 11.66 | 40.2 | 106.67 | 165.99 | 424.3 |
| Cash Income Tax Paid | 8.86 | 12.61 | 13.69 | 9.57 | 14.13 |
| Levered Free Cash Flow | -19.15 | -55.39 | 5,785 | -4,686 | -1,292 |
| Unlevered Free Cash Flow | -15.59 | -16.35 | 6,050 | -4,027 | -872.42 |
| Change in Net Working Capital | 31.62 | -33.79 | -6,068 | 4,019 | 836.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.